Multimodality local ablative therapy of 23 lung metastases with surgical resection and percutaneous cryoablation in a patient with Li-Fraumeni Syndrome: a case report

Patients with Li-Fraumeni syndrome (LFS) are prone to develop a variety of malignancies due to insufficient activity of the encoded tumor suppressor protein P53, including adrenocortical carcinoma, breast cancer, lung cancer, pancreatic cancer, and sarcoma. In the setting of LFS, local treatment opt...

Full description

Saved in:
Bibliographic Details
Published in:Radiology case reports 2023-10, Vol.18 (10), p.3586-3591
Main Authors: Saenger, Jonathan A., Tahir, Ismail, Födinger, Manuela, Cote, Gregory M., Muniappan, Ashok, Fintelmann, Florian J.
Format: Article
Language:English
Subjects:
Case Report
Cryoablation
Leiomyosarcoma
Li-Fraumeni syndrome
Lung metastasis
Thermal ablation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with Li-Fraumeni syndrome (LFS) are prone to develop a variety of malignancies due to insufficient activity of the encoded tumor suppressor protein P53, including adrenocortical carcinoma, breast cancer, lung cancer, pancreatic cancer, and sarcoma. In the setting of LFS, local treatment options for lung metastases are limited to surgery and thermal ablation since radiotherapy and some systemic therapies predispose patients to additional future malignancies. We present the case of a 45-year-old woman with LFS with leiomyosarcoma metastases to both lungs who underwent bilateral wedge resections to treat a total of eight lung metastases followed by six percutaneous cryoablation sessions to treat 15 additional lung metastases over a period of 24 months. Our case demonstrates the option of multimodal local ablative therapies for lung metastases in patients with LFS, including percutaneous cryoablation.
ISSN:1930-0433
1930-0433
DOI:10.1016/j.radcr.2023.07.047